# Evaluation of Safety and Pharmacokinetics of Single Doses of VBY-376 in Healthy Adults

> **NCT00557583** · PHASE1 · COMPLETED · sponsor: **Virobay Inc.** · enrollment: 48 (actual)

## Conditions studied

- Chronic Hepatitis C Infection

## Interventions

- **DRUG:** VBY 376

## Key facts

- **NCT ID:** NCT00557583
- **Lead sponsor:** Virobay Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2007-11
- **Primary completion:** 2008-02
- **Final completion:** 2008-02
- **Target enrollment:** 48 (ACTUAL)
- **Last updated:** 2013-12-31


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00557583

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00557583, "Evaluation of Safety and Pharmacokinetics of Single Doses of VBY-376 in Healthy Adults". Retrieved via AI Analytics 2026-07-20 from https://api.ai-analytics.org/clinical/NCT00557583. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*